Illumina, Inc.-0.846 %

Daily Stock Price

CEO

Francis A. deSouza


Company Symbol

ILMN


Exchange

NASDAQ


Industry

Biotechnology


Information

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.


*latest update 2020-05-13

Monthly Stock Price

Financial Ratios

Institutional Holders

HolderSharesDate Reported% OutValue
Baillie Gifford and Company17,619,078Mar 30, 202011.99%4,812,122,583
Vanguard Group, Inc. (The)11,749,136Mar 30, 20207.99%3,208,924,024
Blackrock Inc.10,945,014Mar 30, 20207.45%2,989,302,223
State Street Corporation6,085,846Mar 30, 20204.14%1,662,166,259
Edgewood Management Company4,862,068Mar 30, 20203.31%1,327,928,012
Capital Research Global Investors4,213,566Mar 30, 20202.87%1,150,809,145
Sands Capital Management, Inc.3,262,948Mar 30, 20202.22%891,176,357
Morgan Stanley2,912,817Mar 30, 20201.98%795,548,579
Bank Of New York Mellon Corporation2,617,521Mar 30, 20201.78%714,897,335
Geode Capital Management, LLC2,433,358Mar 30, 20201.66%664,598,736

Search a Stock from the NASDAQ 100

We are redirecting you to